GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases

GlycA is a biomarker of systemic inflammation, quantifying both the protein concentrations and glycosylation states of several acute phase proteins. GlycA has been shown to be associated with both subclinical atherosclerosis and with cardiovascular disease (CVD). GlycA levels are higher in acute and...

Full description

Bibliographic Details
Main Authors: Nehal N. Mehta, Amit K. Dey, Reethika Maddineni, William E. Kraus, Kim M. Huffman
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:American Journal of Preventive Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667720301203